Predictive Factors And Long-Term Visual Outcomes After Anti-Vascular Endothelial Growth Factor Treatment Of Retinal Angiomatous Proliferation
Maiko Maruyama-Inoue, Shimpei Sato, Shin Yamane, Kazuaki Kadonosono Department of Ophthalmology, Yokohama City University Medical Center, Yokohama, JapanCorrespondence: Maiko Maruyama-InoueDepartment of Ophthalmology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Ka...
Saved in:
Main Authors: | Maruyama-Inoue M, Sato S, Yamane S, Kadonosono K |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/a86303419e6a445ba6f68caf68b45e2b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation
by: Arias L, et al.
Published: (2016) -
Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
by: Fouda SM, et al.
Published: (2017) -
Efficacy of Aflibercept versus Ranibizumab in the treatment of diabetic macular edema
by: Xiu-Xian Wang, et al.
Published: (2021) -
Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab
by: Nudleman E, et al.
Published: (2016) -
Evaluation of peripheral fundus autofluorescence in eyes with wet age-related macular degeneration
by: Suetsugu T, et al.
Published: (2016)